Last reviewed · How we verify
FM-602
FM-602 is a bowel preparation agent that works as an osmotic laxative to cleanse the colon.
FM-602 is a bowel preparation agent that works as an osmotic laxative to cleanse the colon. Used for Bowel preparation prior to colonoscopy or other colorectal procedures.
At a glance
| Generic name | FM-602 |
|---|---|
| Sponsor | C.B. Fleet Company, Inc. |
| Drug class | Osmotic laxative |
| Modality | Small molecule |
| Therapeutic area | Gastroenterology |
| Phase | Phase 2 |
Mechanism of action
FM-602 is formulated to draw water into the intestinal lumen through osmotic action, promoting bowel evacuation and cleansing. Developed by C.B. Fleet Company, a manufacturer specializing in gastrointestinal products, it is designed to prepare patients for colonoscopy or other colorectal procedures by clearing fecal matter from the colon.
Approved indications
- Bowel preparation prior to colonoscopy or other colorectal procedures
Common side effects
- Nausea
- Abdominal discomfort
- Vomiting
- Dehydration
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- FM-602 CI brief — competitive landscape report
- FM-602 updates RSS · CI watch RSS
- C.B. Fleet Company, Inc. portfolio CI